中国某国家儿童医学中心经验:神经系统基础疾病儿童疫苗犹豫的常见问题与改进方案
该研究纳入2017—2019年在中国首个免疫咨询门诊寻求接种咨询的2221名神经系统基础疾病儿童,分析其基础疾病与免疫接种状态,并对部分特殊儿童主动随访。结果显示90.9%的儿童延迟接种、4.5%未接种,适龄疫苗覆盖率为56.1%;对2048名(92.2%)儿童建议恢复接种,多数遵从专家建议,家长未报告神经系统病情进展或加重。结论认为疫苗犹豫在该群体中普遍存在,专业咨询有助于建立疫苗信心,且接种总体安全。
要点
- 2221名神经系统基础疾病儿童中,90.9%延迟接种、4.5%未接种,适龄疫苗覆盖率56.1%。
- 对2048名(92.2%)儿童建议恢复接种,多数遵从专家建议。
- 家长未报告接种后神经系统病情进展或加重,接种总体安全。
核心结论
- 疫苗犹豫是中国各类神经系统疾病儿童的常见问题,专业免疫咨询有助于为该特殊儿童群体建立疫苗信心,且接种总体安全。
研究设计与样本
- 纳入2017—2019年在中国首个免疫咨询门诊寻求接种咨询的2221名神经系统基础疾病儿童,分析基础疾病与免疫接种状态,并告知所有家长自我报告补种后不良事件。
- 对遗传性疾病、免疫相关脑病和癫痫等特别关注的儿童进行主动随访,监测对建议的依从性和不良事件。
主要发现
- 所有接受咨询的儿童均被评估为无免疫接种禁忌证。
- 2019名(90.9%)神经系统基础疾病儿童延迟接种,99名(4.5%)未接种,适龄疫苗覆盖率为56.1%。
- 最受关注的疫苗为百白破联合疫苗、白破联合疫苗、脑膜炎球菌多糖疫苗和日本脑炎疫苗。
- 对2048名(92.2%)儿童建议恢复接种,多数接受咨询的儿童遵从专家建议。
- 家长未报告神经系统病情进展或加重。
临床怎么用
- 作者认为专业免疫咨询有助于为神经系统基础疾病儿童建立疫苗信心,且该群体接种总体安全。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Parents and healthcare providers usually defer or avoid immunization for children with neurological conditions. This study was conducted to investigate the common issues of immunization among these special children and the impact of specialists' recommendation on improving immunization practice. METHOD: We included 2,221 children with underlying neurological conditions seeking vaccination consultation at the first Immunization Advisory Clinic in China during 2017-2019. The primary neurological conditions and immunization status were analyzed. All parents were informed to self-report the adverse events following catch-up immunization. For specially concerned children with hereditary disorders, immune-related encephalopathy and epilepsy, we conducted the active follow-up to monitor the compliance with recommendation and the adverse events. RESULT: All counselling children were assessed as not having any contraindication of immunization. A total of 2,019 (90.9%) children with underlying neurological conditions had delayed immunization and 99 (4.5%) had non-immunization. The coverage rate of age-appropriate vaccines was 56.1%. The most concerned vaccines were diphtheria, tetanus and acellular pertussis combined vaccine, diphtheria and tetanus combined vaccine, meningococcal polysaccharide vaccine and Japanese encephalitis vaccine. Resuming immunization was recommended for the 2,048 (92.2%) children. Most of counselling children complied with the specialists' recommendation. Neither progress nor flaring of the neurological medical conditions was reported from parents. CONCLUSION: Vaccine hesitancy was a common issue for Chinese children with all kinds of neurological conditions. Specialized consultation on immunization is helpful to build vaccine confidence for the special children. Immunization for children with underlying neurological conditions is generally safe.
引用
- Feng T, Wang X, Li J, et al. Common issues and improvement solution of vaccine hesitancy in children with underlying neurological conditions: Experience from one National Children's Medical Center in China. Vaccine. 2022. PMID: 36470687. doi:10.1016/j.vaccine.2022.11.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。